BACKGROUND: Nitric oxide (NO) is involved in ovulation, but it is uncertain whether the mechanisms responsible are systemic or local. In vivo and in perfused ovaries, inhibition of nitric oxide synthase (NOS) reduces ovulation. This study used a well-characterized system of isolated follicle culture to assess which isoforms of NOS might be involved at the follicular level. METHODS: NOS inhibitors, stimulators and NO donors were used to manipulate the environment of mouse cultured follicles, selectively targeting different isoforms of NOS. Follicle survival and ovulation in vitro were monitored using established markers. RESULTS: Inhibition of endothelial NOS did not affect survival or ovulation of cultured follicles. Inhibition of inducible nitric oxide synthase (iNOS) had mild effects in this system, generally inhibitory of ovulation. NO donors had variable inhibitory effects, including toxic effects. Stimulators of iNOS appeared to show mixed, mostly inhibitory, effects that possibly involved different mechanisms. CONCLUSIONS: The results suggest that relatively minor effects on survival and ovulation in vitro are achieved by modulating the NO pathway, and the marked effects of NOS inhibitors in vivo do not occur in vitro. It is therefore probable that the effects of NOS inhibitors in vivo are mediated via effects outside the follicle.
Introduction
Nitric oxide (NO) is a biochemical messenger with diverse actions in a wide range of physiological systems. NO is involved in various female reproductive processes such as ovulation, implantation and uterine contractility, with potential for pro-fertility and contraceptive medical applications (Maul et al., 2003) . In the ovary, NO is well known to influence blood flow and tissue remodelling at ovulation (Jablonka-Shariff and Olson, 1997) . We previously confirmed the presence of isoforms of nitric oxide synthase (NOS) in mouse follicles at various stages of growth. Using sensitive measures of follicle growth and ovulation in vitro (Mitchell et al., 2002) , we showed that follicle development is severely compromised if NO is reduced by omitting L-arginine, the substrate for NOS (Mitchell et al., 2004) . Others have shown a role for endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS) in mouse and rat oocyte maturation respectively which occurs in the few hours preceding ovulation (Jablonka-Shariff and Olson, 2000; Nakamura et al., 2002) . An understanding of peri-ovulatory NO regulation may hold important information about the potential of follicles and oocytes to produce developmentally competent gametes.
The aim of this study was to analyse the effects of a variety of NOS inhibitors, NOS stimulators and NO donors upon mouse follicle development and ovulation in vitro. The effects upon ovarian function of pharmacological agents that modulate NO have been studied previously using various approaches. NOS inhibitors including aminoguanidine (AG) and N G -methyl-L-arginine (L-NMMA) suppress ovulation in rats in vivo (Shukovski and Tsafriri, 1994) and in vitroperfused ovaries (Hesla et al., 1997) . However, ours is the first study to test effects upon cultured follicles. The absence of systemic influences upon cultured follicles enables local effects to be studied and enables the relative effects of intraand extrafollicular regulation to be distinguished.
Most NOS inhibitors vary in their affinities for the isoforms of NOS (iNOS, nNOS and eNOS) (Rosselli et al., 1998) . Analogues of L-arginine act as competitive inhibitors reversible by addition of excess L-arginine, although prolonged exposure may cause irreversible inhibition (Olken et al., 1994) . N G -Nitro-L-arginine (L-NNA) has greatest affinity for nNOS, less for eNOS, with little effect upon iNOS (Reif and McCreedy, 1995) . N G -Nitro-L-arginine methyl ester (L-NAME) is the methyl ester of L-NNA and inhibits eNOS (Rees et al., 1990) and nNOS (Xia et al., 1996) potently but iNOS weakly (McCall et al., 1991) . L-NMMA is approximately equipotent against all three isoforms in humans (Vallance, 1996) and inhibits the enzymatic activity of iNOS induced by interleukin (IL)-1b pre-treatment in rats (Corbett and McDaniel, 1996) . S-Methylisothiourea sulphate (SMT) is a non-amino acid analogue of L-arginine, which acts as a competitive inhibitor of NOS, having some selectivity for iNOS over eNOS (Szabo et al., 1994) .
The normal physiological profile of NO production cannot easily be replicated. Chemical donors can raise levels of NO, but toxic effects occur at high concentrations because NO is a free radical. Interpretation of experiments using NO donors can be complex as NO exerts negative feedback on its own production, inhibiting NOS (Buga et al., 1993) by interacting with the haem group (Hurshman and Marletta, 1995) and by interfering with nuclear factor (NF)-kB (Park et al., 1997) , a key transcription factor in the promoter region of the iNOS gene.
Other factors may stimulate iNOS production. For example, lipopolysaccharide (LPS) is a component of bacterial cell walls and an endotoxin, which induces the production of inflammatory mediators such as tumour necrosis factor a (TNFa), interferon g and IL-1b (Griffith and Stuehr, 1995) . Both LPS and interferons can increase iNOS mRNA via actions on specific promoter regions of the iNOS gene (Laubach et al., 1995) . In rat and rabbit perfused ovaries, IL-1b can induce ovulation even in the absence of an LH stimulus (Brannstrom et al., 1993) and further increasing the LH-stimulated ovulation rate (Bonello et al., 1996) . These actions appear to be mediated by NO because ovulation was sharply reduced when L-NAME was added together with LH and IL-1b.
Our previous studies detected iNOS and eNOS in the thecal cells and oocyte and also weakly in the granulosa cells of whole mouse ovaries (Mitchell et al., 2004) . Cultured mouse follicles were also positive for iNOS, and the requirement for NOS action for normal follicle growth in vitro was demonstrated by manipulation of levels of NOS substrate (L-arginine), intermediate (N G -hydroxy-L-arginine) and endproduct (L-citrulline) (Mitchell et al., 2004) . In the present study, selective inhibition of iNOS and eNOS has therefore been attempted by applying carefully chosen concentrations of inhibitors to cultured mouse follicles in order to distinguish their effects upon follicle growth and ovulation.
Materials and methods
Follicles were isolated from B6CBF1 mice aged 4 weeks and cultured using methods previously described and characterized in detail (Mitchell et al., 2002) . Briefly, preantral follicles of diameter ,135 mm were manually dissected away from surrounding tissues using 29 gauge needles mounted on syringes. Follicles used in experiments had intact basement membranes, with a centrally located oocyte, granulosa cells of healthy appearance, and a few attached thecal cells. Individual follicles were incubated in drops of 20 ml culture medium under oil. In this system, follicles adhere to the surface of the culture dish, with the basement membrane being breached within a few days in normal conditions. Despite the lack of basement membrane integrity, expanding antra appear in the granulosa layer and a mass of cells persists around the oocyte that remains viable, giving the impression that internal follicle functions are preserved in this system. The flattened follicular architecture affords clear visualization. The culture medium, minimum essential medium a (MEMa), included a standard concentration of 600 mmol/l L-arginine and was supplemented with 5% heatinactivated fetal calf serum and FSH (100 mIU/ml, Metrodin HP; Serono, UK), conditions previously shown to support follicle growth (Mitchell et al., 2002) . Media were refreshed every 2 days. hCG, 1.5 IU/ml, (Profasi; Serono) was added on day 10 of culture and ovulation noted 16, 24, 40 and 48 h later.
Inhibitors of NOS NOS inhibitors and information on their relative inhibitory activities were obtained from Calbiochem (USA). Stock concentrations prepared in basal culture medium were used to supplement follicle growth media. Where necessary, stock aliquots were stored at 2 208C. Inhibitors were present for the duration of the culture at the following final concentrations: L-NNA, 0, 1, 10, 100 mmol/l (66-69 follicles per group, seven experiments); L-NAME. 0, 0.5, 5, 50 mmol/l (49 -56 follicles per group, four experiments); 100, 1000, 10 000 mmol/l (32-34 follicles per group, three experiments); L-NMMA, 0, 0.39, 3.9, 39 mmol/l (102 -105 follicles per group, eight experiments) and 60, 600, 6000 mmol/l (36 -40 follicles per group, two experiments); SMT, 0, 6, 60, 600, 6000 mmol/l (66-130 follicles per group, five to nine experiments).
L-NNA is an L-arginine analogue and is a potent, cell-permeable, reversible, competitive inhibitor of nNOS and eNOS at low concentrations (IC 50 ¼ 25 and 90 nmol/l respectively) and inhibits the activity of iNOS at higher concentrations (IC 50 ¼ 8.1 mmol/l).
L-NAME is the more soluble methyl ester of L-NNA and is a competitive inhibitor of eNOS at IC 50 ¼ 0.5 mmol/l and iNOS at . 1000 mmol/l. L-NAME was used at low (0.5 -50 mmol/l) and high (0.1-10 mmol/l) concentrations. At the low concentrations, only eNOS would be inhibited, whereas at the higher concentrations both iNOS and eNOS would be affected.
L-NMMA is a competitive inhibitor of all three NOS isoforms (IC 50 ¼ 650 nmol/l for nNOS, IC 50 ¼ 700 nmol/l for eNOS and IC 50 ¼ 3.9 mmol/l for iNOS). L-NMMA was used at low (0.39 -39 mmol/l) and high (0.06 -6 mmol/l) concentrations. The low concentrations would be expected to inhibit all three NOS isoforms; however, Griffith and Kilbourn (1996) reported that when the culture medium contains L-arginine, the L-NMMA concentration should be 5 -10-fold higher than that of L-arginine, i.e. up to 6 mmol/l, hence the higher concentration set was applied also.
SMT is a selective inhibitor of iNOS with EC 50 of 2-6 mmol/l (Szabo et al., 1994) .
NO donors
NO donors (Calbiochem) were prepared in basal culture medium immediately prior to use, because they are unstable in solution. The following donors were included in follicle growth media for the duration of culture at the concentrations listed: 3-morpholino-sydnonimine, HCl (SIN-1), 0, 10, 100, 1000 mmol/l (79 -83 follicles per group, seven experiments); S-nitroso-N-acetylpenicillamine (SNAP), 0, 13, 130, 1300 nmol/l (89-95 follicles per group, seven experiments); 1-hydroxy-2-oxo-3,3-bis(3-aminoethyl)-1-triazine (NOC-18), 0, 1, 10, 100 mmol/l and 10 mmol/l [31 -50 follicles per group, three experiments (two for 10 mmol/l)].
The concentrations of SIN-1 (10 -1000 mmol/l) were selected based upon previous publications with rat neurons, liver microsomes and human hepatoma cell cultures (de Groot et al., 1993; Lipton et al., 1993; Gergel et al., 1995) .
The concentrations of SNAP (0.013, 0.13 and 1.3 mmol/l) were selected based upon the work of Henry et al. (1989) showing an EC 50 of 130 nmol/l in bovine arteries.
NOC-18 is a NO donor with a relatively long half-life for NO release (t ½ ¼ 78 mins in PBS at 378C; Hrabie et al., 1993) and each molecule results in the release of two molecules of NO. NOC-18 was added at concentrations between 1 mmol/l and 10 mmol/l.
NOS stimulators
Escherichia coli lipopolysaccharide (LPS, Calbiochem) was added to cultured follicles at final concentrations of 0, 20, 200, 2000 pg/ml; 75 -77 follicles comprised each group (five experiments). The stock solution of LPS (2 mg/ml) in culture medium was stored at 48C.
IL-1b (Calbiochem) was added to follicle cultures at final concentrations of 0, 1, 10 and 100 pg/ml, with 43 -47 follicles per group (four experiments). These doses were chosen as other researchers have used similar concentrations with human chondrocytes requiring 100-500 pg/ml IL-1 for maximum NO production (Hauselmann et al., 1994) . Stock solution was prepared in serum-free culture medium and aliquots were stored for up to 3 months at 2 708C.
Monitoring follicle growth
All follicles were observed daily and their growth recorded using extensively characterized morphological criteria of attachment, basement membrane integrity, granulosa cell outgrowth, antrum formation, oocyte appearance, ovulation and cumulus presence and appearance, as described in detail previously (Mitchell et al., 2002) . At the end of culture, follicles were considered to have survived or not based upon the appearance of the oocyte and granulosa cells. Follicles in which the oocyte was spherical and centrally located, in granulosa which was not overtly degenerate, were considered to have survived. Timely ovulation was defined as the release of the oocyte within 16 h after the hCG stimulus, and delayed ovulation defined as the release of the oocyte between 16 and 48 h of the hCG stimulus. Such ovulation has previously been shown to occur in response to hCG rather than as a result of follicle deterioration. Occasional oocytes extruded from degenerating follicles could be distinguished by their lack of cellular investments and differences in the follicle appearance (Mitchell et al., 2002) .
Statistical analysis
Follicle survival and ovulation were analysed using contingency tables with x 2 , with P , 0.05 considered significant.
Results

NOS inhibitors
Survival rates of mouse follicles cultured in concentrations of L-NNA between 0 and 100 mmol/l varied from 86 to 94% (Figure 1a ). Timely ovulation rates were similar in all groups, ranging from 58 to 64%. There was no significant effect of L-NNA at any concentration.
N
G -Nitro-L-arginine methyl ester (L-NAME) In the presence of 0.5 mmol/l -10 mmol/l L-NAME, follicle survival rates were 75-99% compared to 86% in the control group (Figure 1b) . Timely ovulation rates were highest in the control group (58%) with 18% ovulating late and 10% not responding to the hCG stimulus. Timely ovulation after hCG was significantly reduced relative to controls in 0.1 mmol/l ðP , 0:05Þ, 1 mmol/l ðP , 0:02Þ and 10 mmol/l L-NAME ðP , 0:05Þ. The proportion of follicles undergoing delayed ovulation appeared increased in the presence of L-NAME, resulting in broadly similar total ovulation rates for all groups.
N G -Monomethyl-L-arginine, monoacetate salt (L-NMMA) Follicle survival rates were similar at all L-NMMA concentrations. In the first set of experiments, the highest timely ovulation rate was observed in the control group (71%) compared with 59% in 0.39 mmol/l L-NMMA ðP , 0:05Þ, 67% in 3.9 mmol/l L-NMMA (NSD) and 53% with 39 mmol/l L-NMMA ðP , 0:02Þ (Figure 1c) . Interestingly, at the end of culture, one follicle in this group had retained an intact basement membrane and follicular architecture similar to that reported previously for follicles cultured in the absence of L-arginine (Mitchell et al., 2004) . No significant effects of L-NMMA were observed at the higher concentrations (0.06 -6 mmol/l).
S-Methylisothiourea sulphate (SMT)
Survival rates of 89 -97% occurred for follicles cultured in # 60 mmol/l SMT, whereas survival was significantly ðP , 0:001Þ reduced with 600 and 6000 mmol/l SMT (Figure 1d ). Timely ovulation rates were also drastically reduced with SMT $ 600 mmol/l. Follicles cultured with 600 mmol/l SMT appeared degenerative by day 7, whereas 6000 mmol/l SMT resulted in dark and granular follicles by day 2.
NO donors
3-Morpholino-sydnonimine, HCl (SIN-1)
The survival and ovulation rates were similar (89 -92%) at all concentrations of SIN-1 (Figure 2a) . Figure 2 . Effect of the nitric oxide donors on mouse follicle survival and ovulation in vitro. 3-Morpholino-sydnonimine, HCl (SIN-1) and S-nitroso-N-acetylpenicillamine (SNAP): the timely ovulation rate with 1.3 mmol/l SNAP was significantly lower ðP , 0:05Þ than control. 1-Hydroxy-2-oxo-3,3-bisð3 2 aminoethylÞ-1-triazine (NOC-18): the survival rate was significantly reduced at 10 mmol/l NOC-18 compared to the control ðP , 0:001Þ. The timely ovulation rate was significantly reduced by NOC-18 at 1 mmol/l ðP , 0:02Þ, 10 mmol/l ðP , 0:05Þ and 100 mmol/l ðP , 0:05Þ. A Timely ovulation (up to 16 h post hCG), B ovulation 16 -24 h post hCG, B ovulation 24 -40 h post hCG, B ovulation 40 -48 h post hCG. B Follicles that survived but did not ovulate. Hence, the total bar represents follicle viability.
L.M.Mitchell, C.R.Kennedy and G.M.Hartshorne S-Nitroso-N-acetylpenicillamine (SNAP) SNAP had no effect upon follicle survival rates (89 -94%) at any of the concentrations tested (Figure 2b ). However, there was a significant ðP , 0:05Þ reduction in timely ovulation with SNAP at 1.3 mmol/l compared to control. The lower concentrations did not produce significant results.
1-Hydroxy-2-oxo-3,3-bis(3-aminoethyl)-1-triazine (NOC-18) NOC-18 had no effect on follicle survival (85 -94%) at up to 100 mmol/l; however, only 26% survived with 10 mmol/l NOC-18 ðP , 0:001Þ (Figure 2c) . The timely ovulation rates with 1, 10 and 100 mmol/l NOC-18 were significantly (P , 0.02, P , 0.05, P , 0.05 respectively) reduced compared to control. At 10 and 100 mmol/l NOC-18, all follicles that had not degenerated by day 10 released a nude oocyte in response to hCG.
NOS stimulators
Lipopolysaccharide (LPS)
The apparent increases in follicle survival and timely ovulation rates were not significant. Follicles cultured with LPS were healthy in appearance and similar to control follicles throughout the culture period (Figure 3a) .
Interleukin-1b (IL-1b)
The survival rate was decreased ðP , 0:05Þ at 100 pg/ml IL-1b compared to control, which appeared to be part of a dose-dependent trend (Figure 3b ). The late ovulation rate was significantly increased when IL-1b was present at 1 pg/ml ðP , 0:01Þ compared to control. One follicle cultured with IL-1b ovulated spontaneously (without hCG addition) on day 10, with mucified cumulus cells attached.
Significantly fewer follicles formed antra when cultured with IL-1b . 1 pg/ml, compared to the control group. For follicles with 0, 1, 10 and 100 pg/ml IL-1b, antrum formation occurred in 67, 72, 44% ðP , 0:01Þ and 19% ðP , 0:001Þ respectively. Examples of antral follicles in each group are shown in Figure 4 . Control follicles formed antra from day 5 onwards and developed large antra by day 9. Follicles cultured with 1 pg/ml IL-1b formed antra from day 4 onwards which had grown to a similar large size by day 9. Follicles cultured with 10 and 100 pg/ml IL-1b started to form antra from day 5 onwards, and these became larger by the end of culture, but did not expand to the same extent as controls. Generally fewer follicular cells were present than in the control.
Discussion
Substantial evidence implicates NO in ovulation, but this arises from studies performed either in vivo, where vascular and endocrine effects are present (Shukovski and Tsafriri, 1994; Bonello et al., 1996; Hesla et al., 1997; JablonkaShariff and Olson, 1998; Jablonka-Shariff et al., 1999a,b) or in perfused ovaries (Bonello et al., 1996; Hesla et al., 1997; Mitsube et al., 1999) where media flow and other ovarian factors could affect ovulation. Therefore, it remains unclear whether there is a local, intrafollicular role of NO in ovulation. This seems likely in view of the presence of NOS in follicles and oocytes (Jablonka-Shariff and Olson, 1997; Mitchell et al., 2004) , and because NO is known to inhibit steroidogenesis of cultured granulosa cells (Van Voorhis et al., 1994; Dave et al., 1997) .
In the present study, we investigated the role of the different NOS isoforms using pharmacological inhibitors having different relative affinities. All these experiments were performed in medium containing L-arginine, to ensure that the NOS pathway was intact. The low numbers of cells present precluded measuring nitrite using the Griess reaction or by real-time electrochemical measurement of NO (G.M. Hartshorne, unpublished data). Hence, the local effectiveness of the inhibitors and other agents could not be quantified by direct NO measurement.
NOS inhibitors competitively block NO production. Their functional groups can interact with iron groups, which may produce non-specific reactions (Peterson et al., 1992) . We found no effect of L-NNA upon follicle survival or ovulation. Reif and McCreedy (1995) demonstrated that L-NNA did not affect purified iNOS at the concentrations used here although eNOS was inhibited. In our experiments, L-NNA transport may have been inhibited by L-leucine and L-phenylalanine present in the culture media (Griffith and Kilbourn, 1996) . While higher concentrations might improve availability, specificity for eNOS would be lost. We therefore sought other inhibitors.
L-NAME is more soluble than L-NNA (Griffith and Kilbourn, 1996) and was used at 0.5, 5 and 50 mmol/l to inhibit eNOS. Under these conditions, total ovulation rates remained similar. While the percentage of follicles that ovulated on time appeared lower with L-NAME, this observation was not significant. A significant reduction in timely ovulation occurred with higher levels of L-NAME (0.1 -10 mmol/l) affecting both eNOS and iNOS . Delayed ovulation seemed to be increased by all concentrations of L-NAME.
L-NMMA inhibits all isoforms of NOS. While two of the low doses significantly reduced timely ovulation, this was not dose-dependent. L-NMMA is required at a concentration 5-10-fold . L-arginine for . 90% inhibition of NOS (Griffith and Kilbourn, 1996) , however, L-NMMA is converted to L-citrulline and NO at 5% efficiency relative to L-arginine (Olken and Marletta, 1993) . We previously showed that L-citrulline can partially restore follicle survival and ovulation in vitro if L-arginine is absent (Mitchell et al., 2004) .
SMT is a 10 -30-fold more potent inhibitor of iNOS than L-NMMA (Szabo et al., 1994) . SMT at $ 600 mmol/l sharply reduced follicle survival and ovulation compared to L-NMMA at the same concentration. No effect was evident at # 60 mmol/l SMT. The most likely explanation is that SMT is toxic, as the highest dose caused degeneration within 2 days, i.e. shorter than the 5 days taken for L-arginine deprivation to affect follicle development in vitro (Mitchell et al., 2004) . However, SMT is not toxic up to 10 mmol/l in mouse macrophages and rat smooth muscle (Szabo et al., 1994) .
In summary, the results obtained with NOS inhibitors were not conclusive, but suggested that eNOS does not have a role in the in vitro follicle culture system, since its inhibition appeared not to affect ovulation. The role of other isoforms such as iNOS is less clear. Some evidence of reducing efficiency of ovulation occurred with iNOS inhibitors; however, a clear dose response was lacking and the magnitude of effects was small. Prolonged exposure to competitive inhibitors may have caused accommodation by the cells, and a brief exposure around the time of ovulation might give different results.
The physiological production of NO is impossible to reproduce experimentally because of NO's local production and short half-life. High NO concentrations (10 -100 mmol/l) are potentially toxic to cells (Griffith and Kilbourn, 1996) and may be obtained using NO donors or when stimulating iNOS with IL-1b or LPS. High NO levels can cause DNA strand breaks and fragmentation (Forstermann et al., 1995) . Chemical donors result in high levels which decline exponentially, effectively producing a pulse of NO at each medium change. de Groot et al. (1993) reported that SIN-1 at 1, 10 and 100 mmol/l released NO to levels of 1^0.2, 6.5^1 and 26.4^2.4 mmol/l in 30 min respectively. The concentrations of NO produced by donors cannot be measured in our system, but it is clear that their dynamics would be different to that arising from enzymatic conversion of L-arginine. NO donors did not significantly affect follicle survival at the concentrations tested and did not appear to be toxic. SIN-1 at 1 mmol/l (the highest dose used here) was slightly toxic to human hepatoma cells (Gergel et al., 1995) . SIN-1 also produces superoxide which may have biological effects (Hogg et al., 1992) . NOC-18 was reported not to produce toxic metabolites (Hrabie et al., 1993) , but caused dosedependent apoptosis in mouse macrophages (Shimoaka et al., 1995) .
NO donors resulted in few effects upon ovulation. There was a tendency towards a dose-dependent reduction in timely ovulation, which might have occurred due to damage of some cells by artificially elevated NO. However, ovulation was not promoted, as might potentially have been anticipated. In addition to the non-physiological mode of NO presentation, these results might also be explained by NO exerting negative feedback on NOS enzymes (Buga et al., 1993) .
Factors stimulating local NO production would potentially produce a more physiologically relevant result. LPS is a component of the cell wall of gram negative bacteria and is known to induce iNOS mRNA in macrophages (Weisz et al., 1994) and hepatocytes (Geller et al., 1993) . With LPS from 20 to 2000 ng/ml, non-significant increases in timely ovulation (8 -10% higher) and survival rates (3 -6% higher) were observed. These results appeared to have a different profile to the other NO modulators employed but were non-significant. This might support the notion that local NO production might promote ovulation.
IL-1b is a cytokine that stimulates iNOS induction by binding to cell surface receptors on theca and granulosa cells (Adashi, 1997) . IL-1b, at 10-100 ng/ml, is reported to be a potent survival factor for rat pre-ovulatory follicles, mediating its effects via NO (Chun et al., 1995) ; however, here, IL-1b decreased timely ovulation, and survival rates were reduced with levels . 10 pg/ml. Possible explanations for this interesting difference include the use by Chun et al. (1995) of short term (1 day) cultures of individually dissected, gonadotrophin-stimulated pre-ovulatory follicles, which might be less sensitive to the potentially toxic effects of IL-1b, which may be stage-specific (Markstrom et al., 2002) . Differences between rat and mouse follicles, the duration of exposure and the possibility of other IL-1b effects exerted via different pathways may also be important. Our data suggest that high concentrations of IL-1b may be toxic to mouse follicles in vitro. Timely ovulation was inhibited, although total ovulation was not affected. The features of follicles cultured with IL-1b (reduced cell number and antrum expansion, but no major effect on survival or darkening of granulosa cells), were different to those when L-arginine was omitted (major reduction in survival, darkened granulosa; Mitchell et al., 2004) which might suggest that IL-1b produced the observed results other than via its effects on NO.
The role of the different isoforms of NOS in follicle growth and ovulation has proved difficult to clarify using the present approach, for several likely reasons. NO is potentially toxic and so mechanisms to ensure its control, including homeostatic feedback from end-products (Buga et al., 1993) via NOS inhibition, and potentially via other intracellular regulators may occur. Other parallel pathways might also have to be inhibited before a significant effect on ovulation would be evident. Other authors, using mice genetically modified to be deficient in either iNOS or eNOS, recently concluded that eNOS was the major isoform affecting the number of oocytes released by ovulation induction (Hefler and Gregg, 2002) . However, , 50% inhibition of ovulation occurred in all mice, indicating that eNOS was not the only factor involved. Since the vascular role of eNOS remained intact in iNOS-deficient mice, unlike in the follicle culture system, minor local effects of iNOS, such as were evident in this study, may not have been apparent in their study.
Overall, our study suggests that while NO clearly has a role in follicle growth and ovulation, the importance of the local intrafollicular mechanism, principally involving iNOS, is secondary to the role of effects mediated by extrafollicular eNOS. The profound inhibition of ovulation achieved with NOS inhibitors in vivo was not reproduced in vitro.
